The Latest Breaking News from Eli Lilly

The pharma giant’s stock has been under pressure since the Greenland issue has been in the spotlight.

Eli Lilly is scheduled to release its Q4 earnings report next month, and analysts forecast triple-digit profit growth.

Patients can watch a video on how to de-stress in the same place they fill their prescriptions.

Elon Musk’s preference for Eli Lilly’s Mounjaro over Novo Nordisk’s Ozempic has sparked increased interest in weight-loss drug stocks.

Eli Lilly is very close to joining the $1 trillion club. Should you buy shares now?

All-Pro safety Brian Dawkins comments on how NFL defenses have adjusting to the league's changing rules w/ @EdEastonJr

Eli Lilly, plus two other massive companies, just announced double-digit percentage increases in their quarterly dividend payments.

Novo Nordisk A/S is moving closer to adding more sales for its blockbuster GLP-1 drug semaglutide to treat a chronic liver disease.

The healthcare industry is set for growth due to the growing demand for quality treatments and ongoing progress in medical technology. Hence, investors might consider investing in healthcare stocks, Eli Lilly (LLY), Thermo Fisher Scientific (TMO), and Abbott Laboratories (ABT) for a healthy portfolio in 2025. Read more….

Construction on the facility in Kenosha County, Wis., is expected to begin next year.

Eli Lilly invests billion to boost manufacturing capabilities, expanding in Wisconsin and Indianapolis to meet growing market demand.